UNIVERSITY OF CALIFORNIA, IRVINE
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private, Subsidiary
- Established
- 1965-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.uci.edu
Overall Diet Quality and Breast Cancer Risk
Completed
- Conditions
- Invasive Breast CancerIncident Breast Cancer
- First Posted Date
- 2017-10-06
- Last Posted Date
- 2017-10-11
- Lead Sponsor
- University of California, Irvine
- Target Recruit Count
- 96959
- Registration Number
- NCT03304171
Maternal Emotions and Diet in Pregnancy
Not Applicable
Completed
- Conditions
- Pregnancy RelatedGlucose Intolerance During PregnancyStress, Psychological
- Interventions
- Behavioral: Placebo Non-stress taskBehavioral: Trier Social Stress Test
- First Posted Date
- 2017-09-11
- Last Posted Date
- 2021-05-13
- Lead Sponsor
- University of California, Irvine
- Target Recruit Count
- 38
- Registration Number
- NCT03278392
- Locations
- 🇺🇸
UCI Medical Center, University of California, Irvine, Orange, California, United States
Trial of Tadalafil, Tamsulosin and Combination for Access Sheath Deployment
Phase 4
- Conditions
- Nephrolithiasis
- Interventions
- First Posted Date
- 2017-07-26
- Last Posted Date
- 2021-04-19
- Lead Sponsor
- University of California, Irvine
- Target Recruit Count
- 220
- Registration Number
- NCT03229889
- Locations
- 🇺🇸
UC Irvine Health, Orange, California, United States
A Pilot Feasibility Trial of Thyroid Hormone Replacement in Dialysis Patients
Not Applicable
- Conditions
- Kidney Diseases, ChronicThyroid Disease
- Interventions
- Drug: Placebo Oral Tablet
- First Posted Date
- 2017-06-19
- Last Posted Date
- 2021-06-14
- Lead Sponsor
- University of California, Irvine
- Target Recruit Count
- 96
- Registration Number
- NCT03191188
- Locations
- 🇺🇸
University Dialysis Center of Orange, Orange, California, United States
Phase-I Trial of Pembrolizumab and Percutaneous Cryoablation Combination Followed by Nephron-Sparing Surgery or Cytoreductive Nephrectomy in Locally Advanced and Metastatic Renal Cell Carcinomas
Phase 1
Withdrawn
- Conditions
- Renal Cell CarcinomaMetastatic Kidney Cancer
- Interventions
- First Posted Date
- 2017-06-16
- Last Posted Date
- 2021-04-05
- Lead Sponsor
- University of California, Irvine
- Registration Number
- NCT03189186
- Locations
- 🇺🇸
UC Irvine Health Department of Urology, Orange, California, United States
Emotion Regulation and Pain in Children With Cancer
Not Applicable
Completed
- Conditions
- Cancer
- Interventions
- Behavioral: Distraction ConditionBehavioral: Reapprasial ConditionBehavioral: Reassurance Condition
- First Posted Date
- 2017-04-28
- Last Posted Date
- 2017-04-28
- Lead Sponsor
- University of California, Irvine
- Target Recruit Count
- 73
- Registration Number
- NCT03133507
Comparison of Nifedipine Versus Indomethacin for Acute Preterm Labor
Not Applicable
Completed
- Conditions
- Obstetric Labor, Premature
- Interventions
- First Posted Date
- 2017-04-26
- Last Posted Date
- 2021-11-05
- Lead Sponsor
- University of California, Irvine
- Target Recruit Count
- 36
- Registration Number
- NCT03129945
- Locations
- 🇺🇸
University of California, Davis, Sacramento, California, United States
🇺🇸University of California, Irvine, Orange, California, United States
🇺🇸University of California, Los Angeles, Los Angeles, California, United States
Project PROTECT: Protecting Nursing Homes From Infections and Hospitalization
Phase 4
Completed
- Conditions
- HospitalizationInfection
- Interventions
- Drug: Iodophor (10% povidone-iodine)
- First Posted Date
- 2017-04-18
- Last Posted Date
- 2023-12-27
- Lead Sponsor
- University of California, Irvine
- Target Recruit Count
- 13952
- Registration Number
- NCT03118232
- Locations
- 🇺🇸
Buena Vista Care Center, Anaheim, California, United States
🇺🇸Walnut Village Rehabilitation and Care Center, Anaheim, California, United States
🇺🇸Gordon Lane Care Center, Fullerton, California, United States
Wearable Device for Motivating Hand Use After Stroke
Not Applicable
Completed
- Conditions
- Cerebral Stroke
- Interventions
- Device: Manumeter
- First Posted Date
- 2017-03-21
- Last Posted Date
- 2021-03-29
- Lead Sponsor
- University of California, Irvine
- Target Recruit Count
- 17
- Registration Number
- NCT03084705
- Locations
- 🇺🇸
University of California, Irvine, Irvine, California, United States
Effect of Ultra-low Dose Naloxone on Remifentanil-Induced Hyperalgesia
Phase 2
Recruiting
- Conditions
- Hyperalgesia
- Interventions
- First Posted Date
- 2017-02-28
- Last Posted Date
- 2024-08-23
- Lead Sponsor
- University of California, Irvine
- Target Recruit Count
- 105
- Registration Number
- NCT03066739
- Locations
- 🇺🇸
UC Irvine Medical Center, Orange, California, United States
© Copyright 2025. All Rights Reserved by MedPath